Chronic hepatitis C. Implications for health-related quality of life

M Heitkemper1, M Jarrett, E M Kurashige

  • 1School of Nursing, Department of Biobehavioral Nursing and Health Systems, Box 357266, University of Washington, Seattle, Washington 98195, USA.

Insights

Chronic hepatitis C significantly impacts patients' quality of life, affecting physical and mental well-being even without severe complications. This highlights the need for nursing interventions focused on symptom management.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Quality of Life Research

Background:

  • Hepatitis C virus (HCV) infection is a major public health concern, affecting millions with many unaware of their status.
  • Chronic hepatitis C can progress to cirrhosis in 15% of cases within 20 years.
  • Existing research indicates a negative impact of chronic hepatitis C on health-related quality of life (HRQoL).

Purpose of the Study:

  • To review the current understanding of how chronic hepatitis C affects HRQoL.
  • To examine HRQoL during pharmacologic treatment and post-liver transplantation for hepatitis C.
  • To identify gaps in research regarding longitudinal HRQoL studies and associated factors.

Main Methods:

  • Literature review of cross-sectional and longitudinal studies.
  • Analysis of research on HRQoL in patients with chronic hepatitis C.
  • Examination of studies considering treatment and transplantation outcomes.

Main Results:

  • Patients with chronic hepatitis C report feeling unwell and experience significant physical and mental well-being changes.
  • HRQoL is negatively affected even in patients without major disease complications.
  • Limited prospective studies exist, particularly concerning symptoms, disease progression markers, and immune function.

Conclusions:

  • Chronic hepatitis C substantially diminishes patients' perceived health and well-being.
  • Findings have significant implications for nursing care, emphasizing symptom reduction and self-care management.
  • Further intervention studies are needed to address the impact on quality of life.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...